Atlas Trials

Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment

Clinical trial NCT01271387 · COMPLETED

Trial details

NCT number
NCT01271387
Sponsor
Vanda Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2011-01-01
Primary completion
2011-08-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.